Last reviewed · How we verify
Red clover
At a glance
| Generic name | Red clover |
|---|---|
| Sponsor | National Center for Complementary and Integrative Health (NCCIH) |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Polyphenol Metabolism and Personalized Nutrition in Menopause (PolyPause). (NA)
- Effect of Red Clover on Menopause Symptoms and Lipid Profile (NA)
- Isoflavone Treatment for Postmenopausal Osteopenia. (NA)
- Red Clover Isoflavones in Postmenopausal Women With Urge Urinary Incontinence and Overactive Bladder (NA)
- The Bioavailability of Red Clover Isoflavones (NA)
- Red Clover Botanical Dietary Supplements - Metabolism and Safety in Women (NA)
- Effects of Fermented Red Clover on Muscle Strength and Muscle Mass (NA)
- Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Red clover CI brief — competitive landscape report
- Red clover updates RSS · CI watch RSS
- National Center for Complementary and Integrative Health (NCCIH) portfolio CI